Sertcelik M.N.,Ankara Diskapi Yildirim Beyazit Training and Research Hospital 1 |
Bozkurt I.H.,Karaman State Hospital |
Yalcinkaya F.,Ankara Diskapi Yildirim Beyazit Training and Research Hospital 1 |
Zengin K.,Ankara Diskapi Yildirim Beyazit Training and Research Hospital 1
BJU International | Year: 2011
Study Type - Therapy (case series) Level of Evidence 4 What's known on the subject? and What does the study add? Milroy reported 84% success at a mean of 4.5 years follow-up by usage of a permanently implantable "urolume" spent in 1993. Memotherm was developed later, especially for urologic use. Our study is one of the largest in this urea, with a high number of patients and a long follow-up period. OBJECTIVE • To evaluate the effectiveness and long-term results of permanent urethral stent (Memotherm) implantation in the treatment of recurrent bulbar urethral stricture. PATIENTS AND METHODS • In all, 47 patients with a history of previous unsuccessful treatment for bulbar urethral stricture were treated using Memotherm bulbar urethral stents between 1998 and 2002. • Long-term follow-up data was analysed and discussed. RESULTS • At the end of the 7-year period 37 of 47 patients (78.7%) had been treated successfully. • Post-micturition dribbling incontinence lasting up to 3 months after stent placement occurred in 32 (68.1%) patients, but this was reduced to only seven patients (14.9%) by the 7-year follow-up. • There was stress incontinence of various severities in nine (19.2%) patients at the 1-year follow-up. These patients were those who had stenosed urethral segments adjacent to the external sphincter. At the long-term follow-up <10% of the patients had stress incontinence complaints. CONCLUSION • Memotherm is a good treatment option in patients with recurrent bulbar urethral stricture of any cause. © 2011 BJU INTERNATIONAL.